Just in case anyone has forgotten, we have an FDA EFS trial just about to begin. That’s a big potential catalyst.
Also in relation to new institutional investors, we only just recently got news of a new European fund in the top 10. That looks like new institutional investment to me.
AVR Price at posting:
$22.45 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)